ZCA
MDCO

Zeke Capital Advisors’s Medicines Co MDCO Stock Holding History

Zeke Capital Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,000
Closed -$450K – 585
2019
Q3 		$450K Buy
9,000
+481
+6% +$19.2K 0.04% 379
2019
Q2 		$311K Buy
8,519
+612
+8% +$20K 0.03% 461
2019
Q1 		$221K Buy
+7,907
New +$186K 0.02% 529
2018
Q4 		– Sell
-32,750
Closed -$980K – 693
2018
Q3 		$980K Buy
+32,750
New +$1.23M 0.08% 251

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Zeke Capital Advisors's MDCO Position: Q4 2019 in Review

Zeke Capital Advisors sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 9,000 shares — an estimated $450K sold.

Zeke Capital Advisors first reported a position in MDCO in Q3 2018 and held it in 4 quarters. The position peaked at $980K in Q3 2018. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Zeke Capital Advisors reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Zeke Capital Advisors sold 9,000 Medicines Co shares in Q4 2019, an estimated $450K.
  • Zeke Capital Advisors first reported a position in Medicines Co in Q3 2018 and held it in 4 quarters.
  • Zeke Capital Advisors's Medicines Co position peaked at $980K in Q3 2018.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Zeke Capital Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.